Associate Director- Clinical Central Services and Innovation

United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, Clinical ResearchIndustries

Requirements

Candidates should possess a Bachelor’s degree and a minimum of 5 years of experience in clinical drug development, demonstrating a strong working knowledge of GxP regulations, including GMPs, GDPs, and/or GCPs. They should also have experience in supervision, coaching, and/or mentoring others, along with strong networking and interpersonal skills for building relationships.

Responsibilities

The Associate Director of CCSI will create, grow, and maintain a team supporting clinical services and capabilities across functional and therapeutic areas, managing the implementation and scale-up of these services per the strategy and plan. They will enable effective decision-making within the team and with leadership, anticipate and resolve operational issues, ensure team readiness, and manage functional networking and vendor relationships. Furthermore, the role involves organizational leadership, people management, including recruitment, development, and succession planning, and fostering a culture of continuous improvement and inclusion.

Skills

clinical capabilities

mobile health care

telemedicine

virtual trial orchestration

recruitment & retention

digital devices

community-based research

logistics

study coordination

patient engagement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free